Author at Microdose

Keith Fiveson

Keith W Fiveson, Veteran, Author of The Mindfulness Experience, 8 Strategies to Live Life Now, and Founder of the Work Mindfulness Institute. He offers Coaching and Contemplative Psychotherapy. He is an IPI /MAPS certified and trained Psychedelic-Assisted Therapy Provider (PATP) focused on Mindfulness-Based Interventions (MBIs)

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Industry

15 Dec 2023

Kanna: The Power of Plants for Conscious Evolution

In a recent interview with the Mindfulness Experience podcast, Keith Fiveson discussed the power of Kanna for conscious evolution....

By Keith Fiveson

Health & Wellness

7 Apr 2023

Healing With Psychedelics, Virtual Reality & Artificial Intelligence

“Set refers to the subject; setting is the session's environment....

By Keith Fiveson

Culture

10 Mar 2023

Death, Hope, and The Psychedelic Experience

This article looks at death and psychedelics, the use of chaplains, doulas, hospices, and retreats that offer entheogenic experiences in a bid to help ease the impact of death passage....

By Keith Fiveson

Culture

3 Mar 2023

Ancient Civilizations and The Psychedelic Experience

Ancient Civilizations and The Psychedelic Experience....

By Keith Fiveson

Join Our Newsletter for Exclusive Updates, Stories, and More

Culture, Industry

6 Dec 2022

Wonderland Journal: A New Generation of Psychedelic Community & Technology

Keith Fiveson reflects on the Wonderland conference and how psychedelics may help to shape and improve our societies and technologies for the next few decades....

By Keith Fiveson

Culture

21 Oct 2022

Psychedelics and Religious Liberty in the United States

People are turning away from organized religion, seeking new ways to connect and get insight into spirituality — using psychedelics as part of their new religious or spiritual practice....

By Keith Fiveson

Culture

8 Sep 2022

The Medicalization of Sacred Plant Medicines

Like many, I’ve watched the recent resurgence of interest in psychedelics and welcomed it as a promising development in the mental health field....

By Keith Fiveson

Culture

2 Jun 2022

The Psychedelic Hero’s Journey

Psychedelics and the Hero's Journey are a tool for helping us to overcome challenges, to transform, and achieve our goals....

By Keith Fiveson

Science

18 May 2022

Psychedelics and Mindfulness: The Future of Mental Health?

A deeper look at t breathing with Mindfulness Based Interventions (MBIs), combined with psychedelics....

By Keith Fiveson

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

Latest News

You Might Also Like

11 Aug 2026

Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won’t Get You High

Enveric Biosciences is trying to answer one of the trickiest questions in the psychedelic drug space: can you get the antidepressant benefits people associate with psychedelics without the trip? On...

By Madison Roberts

28 Jul 2026

FDA’s New Psychedelic Guidance Signals a Maturing Industry. Now Comes the Hard Part.

For years, the psychedelic medicine industry has operated in largely uncharted regulatory territory. Companies developing psilocybin, LSD, MDMA, and next-generation psychedelic-inspired compounds have often found themselves navigating a clinical landscape...

By Madison Roberts

13 Jul 2026

The Psychedelic Sector Has Grown Up. Wall Street Just Hasn’t Fully Realized It Yet

The sector experienced an early wave of enthusiasm fueled by bold promises, lofty valuations, and the belief that psychedelic medicine would quickly transform mental healthcare. Reality, however, proved more complicated....

By Madison Roberts

28 May 2026

Medical Psilocybin Act

New York lawmakers are officially considering the “Medical Psilocybin Act,” legislation that would create legal access to psilocybin therapy for conditions like PTSD, treatment-resistant depression, substance use disorders, end-of-life distress,...

By Madison Roberts

5 May 2026

PTSD, Policy Shifts, and the Rise of Neuroplastogens: What Enveric’s Latest Data Signals for the Field

By Madison Roberts

21 Apr 2026

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

President Donald Trump’s April 2026 executive order on accelerating treatments for serious mental illness does something the psychedelic industry has been waiting for, and quietly fearing. It removes ambiguity. For...

By Madison Roberts

Keith W Fiveson, Veteran, Author of The Mindfulness Experience, 8 Strategies to Live Life Now, and Founder of the Work Mindfulness Institute. He offers Coaching and Contemplative Psychotherapy. He is an IPI /MAPS certified and trained Psychedelic-Assisted Therapy Provider (PATP) focused on Mindfulness-Based Interventions (MBIs)

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

WordPress Ads